Trade Summary

3 days ago, Cvijic Christine Mikail, serving as Pres, CFO at Neurogene Inc. (NGNE), sold 9,600 shares at $31.25 per share, for a total transaction value of $300,043.00. Following this transaction, Cvijic Christine Mikail now holds 93,640 shares of NGNE.

This sale represents a 9.00% decrease in Cvijic Christine Mikail's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, May 6, 2026 and publicly disclosed via SEC Form 4 filing on Friday, May 8, 2026, 2 days after the trade was made.

Neurogene Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.